Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder	Active, not recruiting	Phase 3	2026-08-12		NCT06922045

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jiangsu BioJeTay Biotechnology Co., Ltd.	2

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Anhui Provincial Hospital	Hefei	China	32
Harbin First Hospital Hematology Tumor Research Center	Harbin	China	1
Henan Cancer Hospital	Zhengzhou	China	1
Hospital of Hematology, Chinese Academy of Medical Sciences	Tianjin	China	2
Huazhong University of Science and Technology Union Hospital	Wuhan	China	1
Jiangsu Provincial Hospital	Nanjing	China	4
Jinan Central Clinical College of Shandong First Medical University	Jinan	China	1
Lanzhou University First Hospital	Lanzhou	China	3
Nanfang Hospital, Southern Medical University	Guangzhou	China	83
North China University of Science and Technology Affiliated Hospital	Tangshan	China	7
Second Hospital of Shanxi Medical University	Taiyuan	China	11
Shenzhen Second People's Hospital	Shenzhen	China	4
Sichuan Academy of Medical Sciences＆Sichuan Provincial People's Hospital	Chengdu	China	1
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	66
The First Affiliated Hospital of Nanchang University	Nanchang	China	18
The Second Affiliated Hospital of Kunming Medical University	Kunming	China	5
Wenzhou People's Hospital	Wenzhou	China	4
Xi'an Central Hospital	Xi’an	China	2